NANO-SATELLITE COMPLEXES
    22.
    发明申请

    公开(公告)号:US20210346478A1

    公开(公告)日:2021-11-11

    申请号:US17232751

    申请日:2021-04-16

    Abstract: The present invention provides, in some embodiments, methods, compositions, systems, and kits comprising nano-satellite complexes comprising: a core nanoparticle complex comprising a biocompatible coating surrounding a nanoparticle core; 3-25 satellite particles attached to, or absorbed to, said biocompatible coating; a plurality of antigenic peptides conjugated to, or absorbed to, said satellite particles; and at least one additional property. In other embodiments, provided herein are nano-satellite complexes comprising: a core nanoparticle complex comprising a biocompatible coating surrounding a nanoparticle core; a plurality of satellite particles attached to, or absorbed to, said biocompatible coating; a plurality of antigenic peptides conjugated to, or absorbed to, said satellite particles; and a plurality of LIGHT (TNFSF14) peptides conjugated to, or absorbed to, said satellite particles. In some embodiments, administration of the nanosatellite complexes to a subject with cancer achieves long-term cancer remission (e.g., when combined with an immune checkpoint inhibitor, such as αPD1).

    Photothermal therapy using magnetic nanoparticles
    24.
    发明授权
    Photothermal therapy using magnetic nanoparticles 有权
    使用磁性纳米粒子的光热治疗

    公开(公告)号:US09533045B2

    公开(公告)日:2017-01-03

    申请号:US14457650

    申请日:2014-08-12

    Abstract: The present invention provides methods, systems, and devices for performing photothermal therapy (e.g., to treat cancer) using photothermal nanoparticles with a biocompatible coating surrounding a highly crystallized Fe3O4 core. In certain embodiments, the highly crystallized Fe3O4 core of the photothermal nanoparticles has an X-ray diffraction (XRD) pattern where the brightest diffraction ring is from the 440 plane. In some embodiments, the photothermal therapy is conducted with a device configured to emit electromagnetic radiation in the wavelengths between about 650 nm and 1000 nm, wherein the device further comprises a visible light source that allows a user to determine where the electromagnetic radiation is contacting a subject.

    Abstract translation: 本发明提供了使用具有围绕高度结晶的Fe 3 O 4核心的生物相容性涂层的光热纳米颗粒进行光热治疗(例如治疗癌症)的方法,系统和装置。 在某些实施方案中,光热纳米颗粒的高度结晶的Fe 3 O 4核心具有X射线衍射(XRD)图案,其中最亮的衍射环来自440平面。 在一些实施例中,光热疗法是用配置成发射大约650nm和1000nm之间的波长的电磁辐射的装置进行的,其中所述装置还包括允许用户确定电磁辐射在哪里接触的可见光源 学科。

    CONJUGATED GOLD NANOPARTICLES
    27.
    发明申请
    CONJUGATED GOLD NANOPARTICLES 有权
    结合金纳米粒子

    公开(公告)号:US20140296551A1

    公开(公告)日:2014-10-02

    申请号:US14212594

    申请日:2014-03-14

    Abstract: The present invention relates to methods, compositions, and kits for generating conjugated gold nanoparticles. In certain embodiments, the present invention provides methods of generating unsaturated conjugated gold nanoparticles by mixing naked gold nanoparticles with a first type of attachment molecules at a molar ratio such that the attachment molecules attach to the naked gold particles at a density level below the saturation level of the naked gold particles (e.g., at a saturation level of 1-99%). In some embodiments, a second type of attachment molecules (e.g., with the opposite charge as the first type of attachment molecules) are mixed with the unsaturated conjugated gold nanoparticles to generate double-conjugated gold nanoparticles (e.g., that are zwitterionic)

    Abstract translation: 本发明涉及用于产生共轭金纳米颗粒的方法,组合物和试剂盒。 在某些实施方案中,本发明提供了通过将裸金纳米颗粒与第一类型附着分子以摩尔比混合以使得附着分子以低于饱和水平的密度水平附着于裸金颗粒的方式来产生不饱和共轭金纳米颗粒的方法 的裸金粒子(例如,在1-99%的饱和度水平)。 在一些实施方案中,将第二类型的附着分子(例如,具有相反电荷作为第一类型的附着分子)与不饱和共轭金纳米颗粒混合以产生双共轭金纳米颗粒(例如,两性离子)

    Core-satellite nanocomposites for MRI and photothermal therapy

    公开(公告)号:US10898595B2

    公开(公告)日:2021-01-26

    申请号:US16694715

    申请日:2019-11-25

    Abstract: The present invention provides methods, compositions, systems, and kits comprising core-satellite nanocomposites useful for photothermal and/or MRI applications (e.g., tumor treatment and/or imaging). In certain embodiments, the core-satellite nanocomposites comprise: i) a core nanoparticle complex comprising a biocompatible coating surrounding a nanoparticle core, and ii) at least one satellite component attached to, or absorbed to, the biocompatible coating. In some embodiments, the nanoparticle core and satellite component are composed of near-infrared photothermal agent material and/or MRI contrast agent material. In further embodiments, the satellite component is additionally or alternatively composed of near-infrared optical dye material.

Patent Agency Ranking